Brian Park, PharmD

Drug Information Specialist https://www.rheumatologyadvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

Young woman smoking cigarettes, drinking vodka and taking pills

General Medicine

Pfizer Expands Varenicline Recall Due to Nitrosamine Impurity

Brian Park, PharmD

September 17, 2021

Pfizer is voluntarily recalling 4 additional lots of its smoking cessation therapy varenicline due to the presence of a nitrosamine impurity.

General Rheumatology

FDA: New Warnings and Limitations Set for Certain JAK Inhibitors

Brian Park, PharmD

September 10, 2021

The revisions are based on a completed review of a large randomized safety clinical trial, which included 4362 patients with rheumatoid arthritis.

of onabotulinumtoxin A is a safe and effective treatment for oab

General Medicine

Pfizer, BioNTech Submit Supplemental BLA for COVID-19 Vaccine Booster

Brian Park, PharmD

September 8, 2021

The application includes data from a phase 3 trial that evaluated a booster dose of Comirnaty in 306 adult participants 18 to 55 years of age who were previously vaccinated with a 2-dose primary regimen.

General Medicine

FDA Issues Marketing Denial Orders for Flavored E-Cigarette Products

Brian Park, PharmD

September 8, 2021

The MDOs were issued to approximately 55,000 flavored ENDS products from JD Nova Group LLC, Great American Vapes, and Vapor Salon and included favors such as Apple Crumble, Dr. Cola and Cinnamon Toast Cereal.

Rheumatoid Arthritis

FDA to Review sNDA for Purified Cortrophin Gel for Rheumatoid Arthritis

Brian Park, PharmD

September 7, 2021

Purified Cortrophin Gel is a purified adrenocorticotropic hormone.

General Medicine

Biologics License Application for Moderna COVID-19 Vaccine Submitted to FDA

Brian Park, PharmD

September 2, 2021

The application includes data from the phase 3 COVE study that evaluated the Moderna COVID-19 vaccine in 30,420 adults 18 years of age and older.

General Medicine

Complaint Prompts FDA Action on Use of Purple Patient Bracelets, Wristbands

Brian Park, PharmD

September 2, 2021

The alert comes after a recent complaint about a purple wristband with a different meaning.

General Medicine

Phase 1 Data Support Booster Dose of Pfizer-BioNTech COVID-19 Vaccine

Brian Park, PharmD

August 26, 2021

The phase 1 study is part of clinical trial program evaluating the safety, tolerability and immunogenicity of a booster dose of the Pfizer-BioNTech COVID-19 vaccine.